Alzamend Neuro Annual Report 2018

Alzamend Neuro, Inc. is a Delaware corporation developing patented intellectual property and immunotherapy approaches to prevent, treat and cure Alzheimer's disease. The company filed this Form 1-K annual report for the fiscal year ended April 30, 2018, disclosing business strategy, financial condition, and forward-looking statements regarding expansion and commercialization plans.